The company's purpose is to provide services, develop and market medical acts and technologies in the field of medical radiation using internal and external sealed and unsealed sources, for diagnostic, therapeutic, image-guided or non-image-guided, multimodal and theranostic purposes, particularly in the field of health and specifically, but not exclusively, in cancer and inflammatory diseases. It may also engage in any medical, clinical, research or development activity directly or indirectly related to its purpose, particularly in the fields of nuclear medicine, radiology, radio-oncology, vectorized internal radiotherapy, radio-ligand therapy, oncological surgery (image-guided or non-image-guided and/or using unsealed radioactive sources), radiopharmacy, pharmacokinetic and dynamic imaging, very large field PET imaging, as well as the production and synthesis of radiopharmaceuticals and radioactive isotopes. The company may: engage in any financial, commercial or industrial activity, movable or immovable, directly or indirectly related to its purpose; create branches or subsidiaries in Switzerland and abroad; participate in all companies having a direct or indirect relationship with its purpose; purchase, use, sell or exchange patents, manufacturing processes and trademarks and the concession or use of related licenses. grant loans or guarantees of all kinds to shareholders, group companies or third parties.